Trials / Completed
CompletedNCT00529269
Measurement of Patient Reported Outcomes in Korean Renal Transplant Patients With and Without Gastrointestinal (GI) Symptoms
Patient Reported Outcomes in Renal Transplant Patients With and Without Gastrointestinal Symptoms
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the impact that GI complaints have on patient-reported outcomes and to determine if there is improvement in patient-reported outcomes when converted from mycophenolate mofetil (MMF) to Enteric-coated mycophenolate sodium (EC-MPS)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Enteric-Coated Mycophenolate Sodium (EC-MPS) |
Timeline
- Start date
- 2006-12-01
- Primary completion
- 2007-06-01
- First posted
- 2007-09-14
- Last updated
- 2017-07-07
Locations
2 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00529269. Inclusion in this directory is not an endorsement.